Physician profile
Joseph Morris
NPI 1174740054
$7,125.31
in general payments reported to CMS, 2019-2025
40 companies · $188 in 2025
The $188 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2020: $3,211 · 2021: $1,640 · 2022: $751 · 2023: $538 · 2024: $535 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,260.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,970.59 | 2020-2024 | Da Vinci Surgical System |
| Davol INC. | $255.57 | 2019-2023 | Phasix Mesh |
| Medtronic, INC. | $189.36 | 2021-2024 | Pteye Parathyroid Detection System |
| Kowa Pharmaceuticals America, INC. | $161.44 | 2022-2023 | Seglentis |
| Tela Bio, INC. | $156.48 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Integra Lifesciences Corporation | $114.48 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Innocoll Pharmaceuticals Limited | $111.71 | 2021-2022 | |
| Phathom Pharmaceuticals, INC. | $95.07 | 2024-2025 | Voquezna |
| Elucent Medical | $86.50 | 2022-2024 | |
| Stryker Corporation | $83.74 | 2020-2021 | |
| Baxter Healthcare | $81.74 | 2020-2024 | Perclot |
| Hologic Sales and Service, LLC | $62.05 | 2023-2024 | Trunode, Biozorb, Localizer |
| Solventum Corporation | $56.04 | 2024 | Activ.A.C., Prevena, V.A.C. Veraflo |
| Braintree Laboratories, INC. | $50.42 | 2023-2025 | Sutab, Suflave |
| Lifenet Health | $44.86 | 2023-2024 | Theragenesis Wound Matrix |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endogastric Solutions, INC | $44.53 | 2022 | |
| Kci USA, INC. | $39.08 | 2020-2023 | Prevena, V.A.C.Ulta, V.A.C. Veraflo |
| Pacira Pharmaceuticals Incorporated | $38.22 | 2023-2024 | Exparel, Iovera, Zilretta |
| Abbott Laboratories | $37.29 | 2020-2025 | Eterna |
| Ets Wound Care LLC | $36.56 | 2025 | Mirragen Advanced Wound Matrix |
| Heron Therapeutics, INC. | $35.12 | 2021-2022 | |
| Bioventus LLC | $30.50 | 2023 | Sonicone Clinic |
| Conmed Corporation | $30.08 | 2024-2025 | Airseal, Visiclear |
| Merck Sharp & Dohme LLC | $27.66 | 2025 | Lynparza, Keytruda |
| Teleflex LLC | $25.78 | 2019-2021 | |
| Intra-Sana Laboratories | $24.76 | 2022 | |
| Boston Scientific Corporation | $23.57 | 2025 | Spyglass Discover |
| Innovation Technologies INC | $23.55 | 2025 | Irrisept |
| Regeneron Healthcare Solutions, INC. | $20.95 | 2023 | Libtayo |
| Acacia Pharma INC | $20.66 | 2021 | |
| Ethicon US, LLC | $20.55 | 2019 | |
| Allergan, INC. | $18.53 | 2019 | |
| Polynovo North America LLC | $17.19 | 2023 | |
| Daiichi Sankyo INC. | $16.72 | 2019 | |
| Reprise Biomedical, INC. | $13.23 | 2021 | |
| Nalpropion Pharmaceuticals LLC | $13.05 | 2019 | |
| Molnlycke Health Care US, LLC | $12.31 | 2024 | Avance, Mepilex Border Post-Op Ag |
| Tactile Systems Technology INC | $12.13 | 2022 | |
| Focal Therapeutics, INC. | $11.70 | 2019 | |
| Ambu INC. | $11.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.